🔎 Trials Near Me

Hjem › Kronisk myelomonocytisk leukæmi › Washington

Kronisk myelomonocytisk leukæmi kliniske forsøg i Washington

10 studier for Kronisk myelomonocytisk leukæmi søger deltagere på steder i Washington.

Byer i Washington

Officiel studietekst (engelsk)

CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia

  • Fred Hutch/University of Washington Cancer Consortium, Seattle
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 17. sep. 2026 · NCT04375631

Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hematopoietic Cell Transplant for the Treatment of Adults Age 60 and Older With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia or Other High-Grade Myeloid Cancer

  • Fred Hutch/University of Washington Cancer Consortium, Seattle
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 20. jul. 2026 · NCT07046078

211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia

  • Fred Hutch/University of Washington Cancer Consortium, Seattle
RekruttererFase 1/2
Alder 18 til 75 · Alle køn · Opdateret 22. jun. 2026 · NCT03128034

211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome

  • Fred Hutch/University of Washington Cancer Consortium, Seattle
RekruttererFase 1/2
Alder 18 til 75 · Alle køn · Opdateret 22. jun. 2026 · NCT03670966

Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies

  • Fred Hutch/University of Washington Cancer Consortium, Seattle
RekruttererFase 2Frivillige med god helbredstilstand velkomne
6 Months · Alle køn · Opdateret 29. maj 2026 · NCT04195633

HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

  • Fred Hutch/University of Washington Cancer Consortium, Seattle
RekruttererFase 1
Op til 80 år · Alle køn · Opdateret 18. maj 2026 · NCT03326921

Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse

  • Fred Hutch/University of Washington Cancer Consortium, Seattle
RekruttererFase 1/2Frivillige med god helbredstilstand velkomne
Alder 18 og opefter · Alle køn · Opdateret 15. maj 2026 · NCT06928662

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

  • Seattle Cancer Care Alliance, Seattle
RekruttererFase 2/3
Alder 18 og opefter · Alle køn · Opdateret 30. apr. 2026 · NCT04256317

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

  • Fred Hutchinson Cancer Center, Seattle
RekruttererFase 2
Alder 18 til 66 · Alle køn · Opdateret 17. mar. 2026 · NCT06859424

Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)

  • Fred Hutchinson Cancer Center, Seattle
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 15. apr. 2025 · NCT06462365

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.